CD19+CD21low B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

(2012) J. L. Allen et al.   BLOOD

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD

(2011) W. B. Clark et al.   BLOOD

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation

(2011) Y. Inamoto et al.   BLOOD

Chronic GVHD: B cells come of age

(2011) G. Socie   BLOOD

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

(2011) M. Srinivasan et al.   BLOOD

Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis

(2011) R. Whittle et al.   BLOOD

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

(2011) S. Arai et al.   BLOOD

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD

(2011) G C Hildebrandt et al.   BONE MARROW TRANSPLANTATION

Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation

(2011) Chiaki Nakaseko et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study

(2011) Z Kuzmina et al.   LEUKEMIA

Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders

(2010) Bart M. Vanaudenaerde et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice

(2010) Hildegard T. Greinix et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia

(2010) Z. Kuzmina et al.   BLOOD

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

(2010) S Thepot et al.   LEUKEMIA

Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease

(2009) Jason W. Chien et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells

(2009) S. Suryani et al.   BLOOD

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

(2009) S. Sarantopoulos et al.   BLOOD

Macrolides in the treatment of bronchiolitis obliterans in allograft recipients

(2009) N Maimon et al.   BONE MARROW TRANSPLANTATION

Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation

(2009) Kirsten M. Williams   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Uncoupling CD21 and CD19 of the B-cell coreceptor

(2009) R. A. Barrington et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells

(2009) M. Rakhmanov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease

(2008) Hildegard T. Greinix et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group

(2007) H. Fujii et al.   BLOOD